Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122637) titled 'A Study on the Impact of Vascepa (icosapent ethyl) on Right Heart Remodeling in Adults with Pulmonary Arterial Hypertension: An Open-Label, Interventional, Exploratory Trial' on April 16.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shanghai General Hospital
Condition:
Pulmonary arterial hypertension
Intervention:
Intervention Group:PAHdrugs+IPE
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-16
Target Sample Size: Intervention Group:20;Control group:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showp...